Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Trial to Asses the Tolerability of AVANZ Mite Mix Immunotherapy

NCT01568190 is registered in ClinicalTrials.gov with ALK-Abelló A/S as lead sponsor.

NCT NCT01568190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01568190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Trial to Asses the Tolerability of AVANZ Mite Mix Immunotherapy
Lead sponsor
ALK-Abelló A/S
Phase
Phase 2/3
Overall status
Completed
Start date
December 31, 2011
Completion date
July 31, 2012
Enrollment
102 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis due to dust mite